🦊/Companies

Acuamark Dx

New York, US · 1 known investors

Find your way into Acuamark Dx

35 people in our graph share verified history with the Acuamark Dx team — schools, employers, funds. One of them is your warm intro.

Dan Malvenunlockedknows Bernard Peperstraete · together at Kauffman Fellows (overlapped)
×10knows the team · via Kauffman Fellows
knows the team · via Tan Tock Seng Hospital Pte Ltd

AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.

Founders & leadership

BPBernard Peperstraete
Bernard Peperstraetein𝕏Co-Founder and CEOBernard Peperstraete is co-founder and CEO of Acuamark Dx, a molecular diagnostics company developing blood-based cancer detection technology. He previously led ACT Biotech, a cancer pharmaceutical company acquired by Eddingpharm, and spent nearly a decade in healthcare venture capital as a partner at NGN Capital, following earlier roles at Novartis, Bristol Myers & Squibb, and Tan Tock Seng Hospital in Singapore, with an MBA from Harvard and training in tropical medicine.

Investors · 1

Competitors · 1

by search overlap

Companies competing with Acuamark Dx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Acuamark Dx do?
AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.
Who founded Acuamark Dx?
Acuamark Dx was founded by Bernard Peperstraete.
Who are Acuamark Dx's investors?
Acuamark Dx's investors include 1955 Capital.
Where is Acuamark Dx headquartered?
Acuamark Dx is headquartered in New York, US.